Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Feb 26, 2009

30339_dirs_2009-02-26_21f479ae-5aa2-427a-afb3-361fb929cf46.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: KEATING ROBERT J (Pres. Europe & Asia Pacific)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-24 Common Stock A 2213 Acquired 28037.1696 Direct
2009-02-24 Common Stock A 2213 Acquired 28037.1696 Direct

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.